Egyptian Rheumatology and Rehabilitation

Table 1 Clinical manifestations of studied patients

From: Evaluation of calprotectin and ischemia-modified albumin serum levels as biomarkers to measure disease activity in Behçet’s disease

	n = 60^a	%
Headache	21	35
Mouth ulcer	15	25.0
Erythema	18	30.0
Genital ulcer	19	31.7
Arthritis	34	56.7
Arthralgia	31	51.7
Nausea	29	48.3
Diarrhea	28	46.7
New ocular	27	45.0
Vascular	26	43.3
Skin pustules	10	16.7
Nervous symptoms	22	36.7

A BDCAF patient index score ≥ 2 was considered as active BD, while a score less than 2 was considered as inactive BD
Active BD in 32 patients (53.3%) while 28 (46.7%) had inactive BD
^aCategories are not mutually exclusive

Back to article page